CLINICAL_TRIALS
trial_result
· 2026-04-01
Clinical Trial Update: Zanubrutinib in Patients With IgG4-Related Disease [Phase 2]
Summary
Phase 2 trial update for zanubrutinib in IgG4-related disease; the study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Matthew C. Baker | Conditions: IgG4 Related Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-04-01